Logo (Merck) 351 (Zontivity vorapaxar sulfate 2.5 mg (2.08 mg base))

Generic Name: vorapaxar

Pill imprint Logo (Merck) 351 has been identified as Zontivity vorapaxar sulfate 2.5 mg (2.08 mg base).

Zontivity is used in the treatment of peripheral arterial disease; thromboembolic disorder; prevention of atherothrombotic events and belongs to the drug class protease-activated receptor-1 antagonists. There is no proven risk in humans during pregnancy. Zontivity vorapaxar sulfate 2.5 mg (2.08 mg base) is not a controlled substance under the Controlled Substance Act (CSA).

Zontivity

Generic Name:

vorapaxar

Imprint:

Logo (Merck) 351

Strength:

vorapaxar sulfate 2.5 mg (2.08 mg base)

Color:

Yellow

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Protease-activated receptor-1 antagonists

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Merck Sharp & Dohme Corp.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.